BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10433373)

  • 21. Diet adherence and gluten exposure in coeliac disease and self-reported non-coeliac gluten sensitivity.
    Løvik A; Skodje G; Bratlie J; Brottveit M; Lundin KE
    Clin Nutr; 2017 Feb; 36(1):275-280. PubMed ID: 26714791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides.
    Auricchio S; De Ritis G; De Vincenzi M; Magazzù G; Maiuri L; Mancini E; Minetti M; Sapora O; Silano V
    Gastroenterology; 1990 Oct; 99(4):973-8. PubMed ID: 2394351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of the gluten content of foods.
    Ciclitira PJ; Ellis HJ
    Panminerva Med; 1991; 33(2):75-82. PubMed ID: 1669839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Properties of Gluten Intolerance: Gluten Structure, Evolution, Pathogenicity and Detoxification Capabilities.
    Balakireva AV; Zamyatnin AA
    Nutrients; 2016 Oct; 8(10):. PubMed ID: 27763541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breakdown of gliadin peptides by intestinal brush borders from coeliac patients.
    Bruce G; Woodley JF; Swan CH
    Gut; 1984 Sep; 25(9):919-24. PubMed ID: 6381246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of the presence of coeliac-activating gliadin-like epitopes in malted barley.
    Ellis HJ; Doyle AP; Day P; Wieser H; Ciclitira PJ
    Int Arch Allergy Immunol; 1994 Jul; 104(3):308-10. PubMed ID: 7518270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological and morphometric assessment of human duodenal biopsies maintained in organ culture. In vitro influences of gluten in coeliac disease.
    Fluge G; Aksnes L
    Scand J Gastroenterol; 1981; 16(4):555-67. PubMed ID: 7323692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The production and characterisation of monoclonal antibodies to wheat gliadin peptides.
    Ellis HJ; Freedman AR; Ciclitira PJ
    J Immunol Methods; 1989 Jun; 120(1):17-22. PubMed ID: 2659671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a gliadin-containing gluten-free product in coeliac patients.
    Ciclitira PJ; Cerio R; Ellis HJ; Maxton D; Nelufer JM; Macartney JM
    Hum Nutr Clin Nutr; 1985 Jul; 39(4):303-8. PubMed ID: 3930437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying toxic fractions of wheat gluten and their effect on the jejunal mucosa in coeliac disease.
    Dissanayake AS; Jerrome DW; Offord RE; Truelove SC; Whitehead R
    Gut; 1974 Dec; 15(12):931-46. PubMed ID: 4448408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coeliac activity of the gliadin peptides CT-1 and CT-2.
    Wieser H; Belitz HD; Idar D; Ashkenazi A
    Z Lebensm Unters Forsch; 1986 Feb; 182(2):115-7. PubMed ID: 3705771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The rise and fall of gluten!
    Aziz I; Branchi F; Sanders DS
    Proc Nutr Soc; 2015 Aug; 74(3):221-6. PubMed ID: 25686620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-evaluation of the techique of organ culture for studying gluten toxicity in coeliac disease.
    Hauri HP; Kedinger M; Haffen K; Gaze H; Hadorn B; Hekkens W
    Gut; 1978 Dec; 19(12):1090-8. PubMed ID: 744495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amino acid composition of peptides remaining after in vitro digestion of a gliadin sub-fraction with duodenal mucosa from patients with coeliac disease.
    Cornell HJ
    Clin Chim Acta; 1988 Sep; 176(3):279-89. PubMed ID: 3180479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro tests indicate that certain varieties of oats may be harmful to patients with coeliac disease.
    Silano M; Dessì M; De Vincenzi M; Cornell H
    J Gastroenterol Hepatol; 2007 Apr; 22(4):528-31. PubMed ID: 17376046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues.
    Pinier M; Fuhrmann G; Galipeau HJ; Rivard N; Murray JA; David CS; Drasarova H; Tuckova L; Leroux JC; Verdu EF
    Gastroenterology; 2012 Feb; 142(2):316-25.e1-12. PubMed ID: 22079593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.
    Shan L; Qiao SW; Arentz-Hansen H; Molberg Ø; Gray GM; Sollid LM; Khosla C
    J Proteome Res; 2005; 4(5):1732-41. PubMed ID: 16212427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Peptide from Kiwifruit Exerts Anti-Inflammatory Effects in Celiac Disease Mucosa.
    Russo I; Del Giorno C; Giangrieco I; Hajji N; Ciardiello MA; Iovino P; Ciacci C
    J Am Coll Nutr; 2019 Jul; 38(5):433-440. PubMed ID: 30794064
    [No Abstract]   [Full Text] [Related]  

  • 39. Amylase-Trypsin Inhibitors in Wheat and Other Cereals as Potential Activators of the Effects of Nonceliac Gluten Sensitivity.
    Reig-Otero Y; Mañes J; Manyes L
    J Med Food; 2018 Mar; 21(3):207-214. PubMed ID: 29315017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel avian single-chain fragment variable (scFv) targets dietary gluten and related natural grain prolamins, toxic entities of celiac disease.
    Stadlmann V; Harant H; Korschineck I; Hermann M; Forster F; Missbichler A
    BMC Biotechnol; 2015 Dec; 15():109. PubMed ID: 26625857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.